Company Summary

Barpat Pharma Limited was set up on Monday the 30th of January 2017. Their current partial address is Limerick, and the company status is Liquidation. The company's current director has been the director of 26 other Irish companies; 12 of which are now closed. Barpat Pharma Limited has 3 shareholders. This Irish company shares its Eircode with at least 76 other companies.

Company Name:Barpat Pharma Limited
Company Status:LIQUIDATION
MEETING OF CREDITORS
Took place on 18/06/2025
Form E2: Notice of Appointment of Liquidator(s)
Effective Date 18/06/2025
Company Address:Psc Accountants & Advisors,
Ivernia Hall, 97 Henry Street,
Limerick, Limerick
Key Executive:Mr O'Rourke
Company Size:Log-In To View

Key Contact Profile

Mr O'Rourke is a Company Director of Barpat Pharma Limited since 2017 and a listed Director of 10 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Barpat Pharma Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
Form B2: Change of Company Registered Office Address18/06/202514/11/2025Join Up
Form C17 - Changes to Particulars of Charge Holder25/04/202523/09/2025Join Up
Form E2: Notice of Appointment of Liquidator(s)18/06/202519/06/2025Join Up
Form G2 - Ordinary Resolution to wind up18/06/202519/06/2025Join Up
Form B1C - Annual Return General30/09/202323/10/2023Join Up
THIS COMPANY HAS 46 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Barpat Pharma Limited.

Company Status:Liquidation
MEETING OF CREDITORS
Took place on 18/06/2025
Form E2: Notice of Appointment of Liquidator(s)
Effective Date 18/06/2025
Latest Credit Movement:
Date of Last Movement:05/08/2025
Latest Accounts Filed:23/10/2023
Report Based on Accounts:31/03/2023
Next Set of Accounts Due:30/09/2024
Overdue:Yes
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Barpat Pharma Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Barpat Pharma Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Barpat Pharma Limited and Anti-Money Laundering checks (AML checks) on Barpat Pharma Limited

Directors details are available to logged in users.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:3

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Barpat Pharma Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

Irish Businesses Face Growing Compliance Pressures

10/11/2025

The results of a recent survey CRIFVision-net carried out of over 550 Irish businesses revealed a significant gap in corporate compliance preparedness

Read More »

Smarter PEP Screening with Vision-net

03/11/2025

In Ireland, the definition of a politically exposed person (PEP) is broadening under the 6th EU Anti-Money Laundering Directive (AMLD6) to include domestic PEPs

Read More »

Entrepreneurial Growth Meets Rising Financial Pressure

13/10/2025

The continued emergence of new firms across multiple sectors reflects resilient confidence in the Irish economy.

Read More »

Strong Startup Growth Signals Record Year Ahead

06/10/2025

Our latest CRIFVision-net data highlights a mixed but promising picture of the Irish economy, with entrepreneurial activity continuing to climb.

Read More »